BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 14871333)

  • 1. Onychomycosis in children: a brief overview with treatment strategies.
    Gupta AK; Skinner AR
    Pediatr Dermatol; 2004; 21(1):74-9. PubMed ID: 14871333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onychomycosis.
    Welsh O; Vera-Cabrera L; Welsh E
    Clin Dermatol; 2010 Mar; 28(2):151-9. PubMed ID: 20347657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis in children: an overview.
    Gupta AK; Skinner AR; Baran R
    J Drugs Dermatol; 2003 Jan; 2(1):31-4. PubMed ID: 12852378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral treatment options for onychomycosis.
    Joseph WS
    J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Rosen T; Stein Gold LF
    Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies for onychomycosis.
    Odom RB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 2):S26-30. PubMed ID: 8784308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Onychomycosis - a Clinical Study.
    Pajaziti L; Vasili E
    Med Arch; 2015 Jun; 69(3):173-6. PubMed ID: 26261386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral therapy for onychomycosis: an evidence-based review.
    de Sá DC; Lamas AP; Tosti A
    Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating onychomycosis.
    Rodgers P; Bassler M
    Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends in onychomycosis therapy: a literature review.
    Hecker D
    Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
    Gupta AK
    J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal therapy for onychomycosis in children.
    Feldstein S; Totri C; Friedlander SF
    Clin Dermatol; 2015; 33(3):333-9. PubMed ID: 25889135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral therapeutic agents in fungal nail disease.
    Roberts DT
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
    Gupta AK; Lambert J
    Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.